The YUMM lines: a series of congenic mouse melanoma cell lines with defined genetic alterations
Related Experiment Video
Updated: Mar 19, 2026
Screening for Melanoma Modifiers using a Zebrafish Autochthonous Tumor Model
Published on: November 13, 2012
Katrina Meeth1, Jake Xiao Wang2, Goran Micevic1
1Department of Pathology, Yale University School of Medicine, New Haven, CT, USA.
Abstract:
The remarkable success of immune therapies emphasizes the need for immune-competent cancer models. Elegant genetically engineered mouse models of a variety of cancers have been established, but their effective use is limited by cost and difficulties in rapidly generating experimental data. Some mouse cancer cell lines are transplantable to immunocompetent host mice and have been utilized extensively to study cancer immunology. Here, we describe the Yale University Mouse Melanoma (YUMM) lines, a comprehensive system of mouse melanoma cell lines that are syngeneic to C57BL/6, have well-defined human-relevant driver mutations, and are genomically stable. This will be a useful tool for the study of tumor immunology and genotype-specific cancer biology.
Insights
New mouse melanoma cell lines (YUMM) offer a valuable tool for cancer immunology research. These syngeneic models enable efficient study of tumor immunology and genotype-specific cancer biology in immunocompetent mice.
Area of Science:
- Oncology
- Immunology
- Genetics
Background:
- The success of cancer immune therapies highlights the need for immunocompetent cancer models.
- Existing genetically engineered mouse models are costly and slow for generating experimental data.
- Transplantable mouse cancer cell lines are crucial for studying cancer immunology.
Purpose of the Study:
- To introduce the Yale University Mouse Melanoma (YUMM) cell lines as a novel resource.
- To provide syngeneic, genomically stable melanoma models with human-relevant mutations for research.
- To facilitate the study of tumor immunology and genotype-specific cancer biology.
Main Methods:
- Development of a comprehensive system of mouse melanoma cell lines.
- Characterization of cell lines for syngeneicity to C57BL/6 mice.
- Identification of well-defined, human-relevant driver mutations and assessment of genomic stability.
Main Results:
- Establishment of the YUMM lines, a versatile set of mouse melanoma cell lines.
- YUMM lines are syngeneic to C57BL/6 mice, possess defined driver mutations, and exhibit genomic stability.
- These cell lines are suitable for transplantation into immunocompetent host mice.
Conclusions:
- The YUMM lines represent a significant advancement for cancer research.
- They provide a powerful, cost-effective tool for investigating tumor immunology.
- These models will aid in understanding genotype-specific cancer biology and developing novel therapies.
